Press Releases & In the News

News on emerging health issues, new trends in medicine and research, and connect with top experts at Mount Sinai.

Filter by:

Press Releases

In the News

Show All

Breast Cancer News

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

Mount Sinai at a Glance

400+ Community Locations

You can access Mount Sinai health care across New York City and beyond

Over 42,000 Employees

Including more than 7,400 primary care physicians and specialists

38 Institutes

Focused on multidisciplinary research, educational, and clinical progress

Instagram

Mount Sinai has launched the AI Small Molecule Drug Discovery Center at the Icahn School of Medicine, integrating artificial intelligence with cutting-edge chemistry and biology to accelerate drug development. By leveraging machine learning, the Center will design, optimize, and predict new drug candidates with unprecedented speed and precision. This AI-driven approach will enable researchers to navigate vast chemical landscapes more efficiently, significantly reducing the time and cost associated with traditional drug discovery.

The Center will focus on developing treatments for diseases with urgent unmet needs, including cancer, metabolic disorders, and neurodegenerative diseases. By combining AI-driven insights with Mount Sinai’s expertise in biomedical research, the initiative aims to revolutionize how new medicines are identified and brought to patients.

Instagram

Congratulations to Brian Brown, on his Induction into the AIMBE College of Fellows!

Brian Brown, PhD, Director of the Icahn Genomics Institute at Mount Sinai, has been elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows—one of the highest distinctions in the field. This honor recognizes his pioneering contributions to gene therapy and functional genomics, which have transformed biomedical research and therapeutic development.

Dr. Brown’s innovative work has advanced cutting-edge technologies in cancer, immunology, and genetic disease research, further solidifying Mount Sinai’s leadership in medical breakthroughs.

Please join us in celebrating this incredible achievement!
#IcahnGenomicsInstitute #AIMBEFellow

Press Releases & In the News

Search Breast Cancer News

Breast Cancer News

400+ Community Locations

Over 42,000 Employees

38 Institutes